Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Basilix | BAS | Jun 17, 2024 | 10.30 | 0.00 |
Beaulieu Av Certificates | BEAB | Jun 17, 2024 | 1.19 | 0.00 |
Befimmo SA | BEFB | Jun 17, 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | Jun 17, 2024 | 3 832.88 | -0.01 |
Belreca - Belgian Resources and Capital Company | BELR | Jun 17, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | Jun 17, 2024 | 1.08 | 0.00 |
Belysse Group N.V. | BELYS | Jun 17, 2024 | 0.85 | -3.41 |
Biocartis Group NV | BCART | Jun 17, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Jun 17, 2024 | 0.02 | +1.58 |
Biotalys | BTLS | Jun 17, 2024 | 2.78 | +0.36 |
Boeing | BOEI | Jun 17, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Jun 17, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Jun 17, 2024 | 3.09 | -0.80 |
Brederode S.A. | BREB | Jun 17, 2024 | 114.00 | 0.00 |
Campine nv | CAMB | Jun 17, 2024 | 76.00 | -2.56 |
Candela Invest | CAND | Jun 17, 2024 | 2.80 | 0.00 |
Care Property Invest NV/SA | CPINV | Jun 17, 2024 | 13.94 | -0.14 |
Celyad Oncology SA | CYAD | Jun 17, 2024 | 0.30 | 0.00 |
Cenergy Holdings | CENER | Jun 17, 2024 | 8.90 | +1.37 |
Chevron | CHTEX | Jun 17, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Jun 17, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Jun 17, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Jun 17, 2024 | 57.25 | -0.26 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Jun 17, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Jun 17, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Jun 17, 2024 | 43.24 | -2.44 |
Compagnie du Bois Sauvage S.A. | COMB | Jun 17, 2024 | 258.00 | 0.00 |
Compagnie d`Entreprises CFE SA | CFEB | Jun 17, 2024 | 7.65 | -0.39 |
Connect Group | CONN | Jun 17, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | Jun 17, 2024 | 0.01 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.